300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Theatre
Biotech
Impact
Proptech
Transportation
Medical
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Canada
Liechtenstein
Lebanon
United Kingdom
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Panorama Capital, VC Fund

Panorama Capital

VC Fund

Campbell, United States

Panorama Capital is a VC fund in Campbell focused on Biotechnology and Software. Panorama Capital invests in passionate entrepreneurs building leading companies in life sciences and technology. Founded in 2005 as the successor to the venture capital program of JPMorgan Partners, they take a hands on, highly collaborative approach to investing, bringing to bear the team's extensive operating and investing experience to eachportfolio company. The firm is managed by a seasoned group of life sciences and technology investors who collectively possess over 140 years of investment and industry experience. In addition to their extensive investing experience, they possesses broad experience as executives, entrepreneurs, engineers, and physicians. This collective experience gives Panorama Capital a powerful combination of technical, entrepreneurial, operational, and transactional expertise to help foster the development of their portfolio companies.

Total investments:
47
Last investment:
Lead investor:
38%
Fund size:
$240M
Last fund:

Last updated:

Industries Panorama Capital invests in

BiotechnologySoftwareHealth CareEnterprise SoftwarePharmaceutical

Stages Panorama Capital invests in

Series BSeries CSeries ASeries ESeries D

Countries Panorama Capital invests in

United StatesCanadaChinaEl Salvador

Round sizes

Series A $4.5M–$78MSeries B $6.5M–$148MSeries C $10M–$60M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$4.5M–$78M
Series B
$6.5M–$148M
Series C
$10M–$60M

Investment Focus

Industry

  • Biotechnology 7 (15%)
  • Software 6 (13%)
  • Health Care 6 (13%)
  • Enterprise Software 5 (11%)
  • Pharmaceutical 4 (9%)
See all 64 industries →

Stage

  • Series B 9 (19%)
  • Series C 9 (19%)
  • Series A 6 (13%)
  • Series E 6 (13%)
  • Series D 5 (11%)
See all 10 stages →

Country

  • United States 25 (53%)
  • Canada 3 (6%)
  • China 2 (4%)
  • El Salvador 1 (2%)

Team

NameTitleInvestmentsLinksEmail
CFO Total investments: 0
Find email
Damion Wicker
Damion Wicker Managing Director
Managing Director Total investments: 0
Find email
Michael Jung Principal
Principal Total investments: 3 Find email
Negar Shirazi Operations Team
Operations Team Total investments: 0
Find email
Shahan Soghikian
Shahan Soghikian Managing Director
Managing Director Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
Propi Propi
Propi is a platform that accelerates the rental of residential real estate for landlords and tenants. Propi is revolutionizing the real estate sector in Latam with top-notch proprietary software transforming a painful process with high information asymmetry into a seamless end-to-end experience, for tenants, landlords, and buyers. $2.5M / Pre-Seed / Mar 20, 2023
Jinyuansheng Jinyuansheng
Jinyuansheng is mainly engaged in the development, smelting and deep processing of new energy key metal mineral resources. $148.3M / Series B / Aug 14, 2022
AkroStar AkroStar
AkroStar is a semiconductor firm. $77.7M / Series A / May 19, 2021
AkroStar AkroStar
AkroStar is a semiconductor firm. $61.9M / Seed / Feb 24, 2021
NinthDecimal NinthDecimal
NinthDecimal is the marketing platform powered by location data. It harnesses this data to build a precise understanding of consumers’ physical world behavior. Fortune 500 companies and marquee brands activate this customer intelligence through audience targeting, measurement, insights, and data licensing solutions. By filling the gap inunderstanding how consumers spend the majority of their time, NinthDecimal provides marketers a new model of the customer journey for impactful engagement.It was founded in 2003 and headquartered in San Francisco, California. Series E / Dec 01, 2017
CardioKinetix CardioKinetix
The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function. $50M / Series F / Dec 08, 2014
Auspex Pharmaceuticals Auspex Pharmaceuticals
Auspex Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases. The company's pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with Huntington’s disease, tardivedyskinesia, and Tourette syndrome, as well as other orphan indications. $20M / Series E / Jan 08, 2014
Beyond the Rack Beyond the Rack
Montreal-based Beyond the Rack is the largest free Canadian private shopping club specializing in exclusive deals for women, men and kids seeking the latest in apparel, accessories, fragrances, furniture, wall art, home goods, electronics and more.Some 15 million active members in Canada, the United States, and beyond use Beyond the Rack toaccess limited-quantity flash deals. Beyond the Rack partners with some of the biggest fashion brands to deliver discounts of up to 80% on designer and fast fashion merchandise with no retail middleman required. More than 3,000 brands have worked with Beyond the Rack, and the site is constantly seeking new partnership opportunities.Beyond the Rack runs 15-25 sales per day, depending on demand and availability. Members receive notification emails in advance of each sale, based on their stated (customizable) preferences. Each Beyond the Rack flash sale typically starts at 10am EST and lasts no more than 48 to 72 hours—or whenever featured merchandise sells out, whichever comes first. Once each event ends, the featured products are no longer available. Beyond the Rack merchandise reviews help buyers evaluate items and decide whether and how much to buy. There are three easy ways to join Beyond the Rack. First, prospective members can simply request membership on the website. The process takes only a few minutes and requires minimal personal information. Second, prospects can take advantage of special promotions offered by Beyond the Rack’s marketing partners.Third, prospects can sign up with referral links provided by current Beyond the Rack members. All three sign-up options are free, with no ongoing membership fees. Even better, all confer the same benefits and opportunities to save on Beyond the Rack’s exclusive flash sales. At times, Beyond the Rack delays new member admissions when application volumes swell. This is to ensure that all members have equal access to flash sale merchandise. Application holds are temporary and all membership requests are addressed as promptly as possible.Beyond the Rack is renowned for its responsive customer service, speedy shipping times, and deep discounts. Members count on the latest fashions delivered to their doors as quickly as possible. It’s no wonder Beyond the Rack was named the fastest-growing internet retailer by trade publication Industry Retailer in 2011 and has notched more than $150 million in sales as of 2013. $25M / Series C / Nov 26, 2013
Zoove Zoove
Zoove provides mobile direct response solutions for mobile carriers and brands to deliver content to people. Enabled across all major U.S. carriers, its StarStar platform empowers marketers to leverage media, mobile, and marketing through a single platform, in order to create any offline-to-online brand experience they desire. StarStar drivesmillions of calls every year for the world's top brands including CBS, Dunkin' Donuts, Ford, Hyatt, NFL and Verizon Wireless. $15M / Series E / May 14, 2013
CardioKinetix CardioKinetix
The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function. $23M / Series E / Mar 01, 2013
See all 47 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Theatre
Biotech
Impact
Proptech
Transportation
Medical
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Canada
Liechtenstein
Lebanon
United Kingdom
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Panorama Capital invest in?

Panorama Capital invests primarily in Biotechnology, Software and Health Care startups, most often at Series B and Series C stage. Most of the 47 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Panorama Capital's check size?

Panorama Capital typically joins rounds of $4.5M–$78M at Series A, $6.5M–$148M at Series B and $10M–$60M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Panorama Capital participates in.

How do I contact Panorama Capital?

Public channels for Panorama Capital include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Panorama Capital?

The team at Panorama Capital includes Audrey Vallen (CFO), Damion Wicker (Managing Director) and Michael Jung (Principal). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Panorama Capital Panorama Capital Find emails